Detalles de la búsqueda
1.
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.
J Hepatol
; 65(2): 280-8, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26952006
2.
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients.
Breast Cancer Res Treat
; 142(1): 81-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24122392
3.
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.
J Hepatol
; 56(5): 1080-1088, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22245896
4.
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group).
Invest New Drugs
; 30(3): 1184-92, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21484249
5.
Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US).
J Cancer Res Clin Oncol
; 148(4): 955-965, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34050396
6.
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center.
J Cancer Res Clin Oncol
; 146(6): 1559-1566, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32189107
7.
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study.
Anticancer Drugs
; 20(2): 97-103, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19209025
8.
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.
J Clin Oncol
; 23(5): 965-72, 2005 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15613696
9.
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.
J Clin Oncol
; 23(23): 5314-22, 2005 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15955899
10.
A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 78(2): 405-17, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27349901
11.
Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer.
Clin Colorectal Cancer
; 5(3): 188-96, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16197622
12.
Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
Melanoma Res
; 15(3): 205-7, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15917703
13.
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).
J Gastrointest Cancer
; 46(2): 109-17, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25707610
14.
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours.
Eur J Cancer
; 51(2): 146-56, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25480557
15.
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.
Eur J Cancer
; 50(12): 2072-81, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24915778
16.
First-in-human phase I study of PRS-050 (Angiocal), an Anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors.
PLoS One
; 8(12): e83232, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24349470
17.
Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) formulation and paclitaxel in polyethoxylated castor oil: a randomized, two-period crossover study in patients with advanced cancer.
Clin Ther
; 35(12): 1946-54, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24290734
18.
A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 71(1): 93-101, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23064954
19.
Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 69(3): 753-61, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22020317
20.
Chemosensitivity of conjunctival melanoma cell lines to single chemotherapeutic agents and combinations.
Br J Ophthalmol
; 96(4): 591-6, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22275346